Published by Alexander Bueso on 7th July 2020
(Sharecast News) - Stock in US-based Corvus Pharmaceuticals nearly doubled on Tuesday after announcing its plans to launch an early state clinical trial for an experimental monoclonal antibody to treat Covid-19.
URL: http://www.digitallook.com/dl/news/story/30891417/...